CM
SRDX

Cigogne Management’s Surmodics SRDX Stock Holding History

Cigogne Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$3.11M Buy
+78,500
New +$3.05M 1.84% 17

Other funds holding SRDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Cigogne Management's SRDX Position: Q4 2024 in Review

Cigogne Management opened a new position in Surmodics (SRDX) in Q4 2024: 78,500 shares worth $3.11M. The stake represents 1.84% of the portfolio and ranks #17 among its holdings.

139 funds tracked by Wall St. Rank hold SRDX as of Q4 2024.

  • Cigogne Management held 78,500 shares of Surmodics worth $3.11M as of Q4 2024.
  • Surmodics was a new Cigogne Management position in Q4 2024.
  • Surmodics made up 1.84% of Cigogne Management's portfolio in Q4 2024, its #17 holding.
  • 139 funds tracked by Wall St. Rank held Surmodics as of Q4 2024.

Based on Cigogne Management's 13F filing for Q4 2024, filed 14 Feb 2025.